,
Pérez-Grijalba, Virginia
Arbizu, Javier
Romero, Judith
Prieto, Elena
Pesini, Pedro http://orcid.org/0000-0002-0656-2384
Sarasa, Leticia
Guillen, Fernando
Monleón, Inmaculada
San-José, Itziar
Martínez-Lage, Pablo
Munuera, Josep
Hernández, Isabel
Buendía, Mar
Sotolongo-Grau, Oscar
Alegret, Montserrat
Ruiz, Agustín
Tárraga, Lluis
Boada, Mercè
Sarasa, Manuel
Funding for this research was provided by:
Araclon Biotech
Instituto de Salud Carlos III (FISS PI10/00954)
Departament de Salut de la Generalitat (RECERCALIA grant 390/06/2009)
Article History
Received: 11 July 2019
Accepted: 22 October 2019
First Online: 1 December 2019
Ethics approval and consent to participate
: The study was approved by the CEIC ethic committee 2009/5455, and all participants provided written informed consent prior to inclusion. Patient recruitment and collection protocols were in accordance with ethical standards according to WMA Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects.
: Consent for publication was provided by every participant of the study.
: VPG, PP, JR, ISJ, LS, IM, and MS were employees of Araclon Biotech at the moment the study and data analysis were carried out. All other co-authors declare that they have no competing interests.